Wire · opportunities
UltiMaker and Bioactivx advance on-demand 3D-printed wound care
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 17 September 2026 · Fusion42 review
UltiMaker and Singapore-based MedTech startup Bioactivx have partnered to develop a scalable, on-demand 3D printing solution for regenerative wound care, with Bioactivx securing HSA approval for its 3D-printed Bioactiv Matrix medical implant. The collaboration aims to decentralize manufacturing, enabling faster treatment access by reducing reliance on cold-chain logistics and centralized production.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You now have a proven template for regulatory-approved 3D-printed medical implants that can be produced on demand near the patient. Build towards disrupting slow, centralised wound care supply chains with localised manufacturing using open 3D printing platforms.
◆ Coverage
1 source · 17 Sep 2026
◆ Related on Wire
◆ Topics